Ifp Advisors, Inc Syros Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.69 - $1.21 $34 - $60	50 New	50 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $34 - $60	-50 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$4.08 - $5.66 $204 - $283	50 New	50 $1,000
Q2 2021 Jul 13, 2021	SELL	$5.01 - $7.48 $110 - $164	-22 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$7.19 - $14.95 $632 - $1,315	-88 Reduced 80.0%	22 $0
Q4 2020 Jan 25, 2021	BUY	$6.66 - $14.66 $732 - $1,612	110 New	110 $1,000
Q4 2017 Jan 24, 2018	SELL	$8.45 - $17.48 $4,225 - $8,740	-500 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$13.52 - $23.75 $6,760 - $11,875	500	500 $7,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.